Revvity | PKI - Pre Tax Profit


Revvity reported $187.24M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Agilent USD 408M 44M Mar/2026
Align Technology USD 148.69M 193K Jun/2026
Bio Techne USD 106.09M 34.87M Jun/2026
Bio-Rad Laboratories USD 542.1M 1.23B Jun/2026
Bruker USD 117M 95.1M Jun/2026
Celltrion KRW 11.84B 1.34B Mar/2026
Charles River Laboratories USD -29.94M 264.16M Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Danaher USD 1.08B 157M Jun/2026
Dentsply International USD -42M 105M Mar/2026
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 11.8B 2.17B Jun/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
Illumina USD 260M 103M Jun/2026
Intuitive Surgical USD 940.4M 15.2M Mar/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Laboratory Of America USD 8.61B 121.8M Jun/2026
Medical Developments International AUD -149K 466K Jun/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Mettler Toledo International USD 209.66M 119.42M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Organigram Holdings CAD -921K 40.8M Mar/2026
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Pharma Mar EUR -993K 2.59M Jun/2026
Qiagen NV USD 157.9M 72.08M Jun/2026
Quest Diagnostics USD 334M 4M Mar/2026
Quidel USD -79.5M 32.9M Mar/2026
Repligen USD 14.15M 12.38M Jun/2026
Revvity USD 187.24M 137.25M Jun/2026
Sartorius EUR 127M 30.8M Jun/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Tilray USD -39.96M 39.19M Sep/2025
Waters USD 356M 444M Jun/2026
Zealand Pharma A/S -394M 12.5M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026